Migden M, Rischin D, Sasane M, Mastey V, Pavlick A, Schmults C, Chen Z, Guminski A, Hauschild A, Bury D, Hudgens S, Chang AL, Rabinowits G, Ibrahim S, Fury M, Lowy I, Li S, Chen C-I. Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s5. Available from: https://jofskin.org/33014/index.php/skin/article/view/1157